January 4, 2013
PET/CT early restaging best suited for prostate cancer with fast-rising PSA
Reported by Health Imaging on December 20, 2012 a study published in the Journal of Urology in January 2013, “After prostatectomy, prostate cancer patients with a short prostate-specific antigen (PSA) doubling time should undergo [11C]choline PET/CT for early restaging to optimize potentially needed salvage therapy.”